Role of fibroblast growth factor during early midbrain development in Xenopus.
Genes encoding fibroblast growth factors (FGFs) are expressed in early Xenopus neurulae in the prospective midbrain-hindbrain boundary (MHB) region of the neural plate. These expression domains overlap those of XWnt-1 and XEn-2, raising the question of the role of FGF signalling in the regulation of these genes, and more generally about the function of FGF during Xenopus midbrain development. We report that explants from the prospective MHB grafted into the anterior neural plate in midneurula stage embryos induce XWnt-1 expression and, at a lower frequency, XEn-2 expression in the vicinity of the graft. Such a process is likely to involve FGF signalling. Implantation of FGF4- or FGF8-soaked beads in the prospective forebrain at neurula and tailbud stages causes the up-regulation of XWnt-1 and XEn-2 in the dorsal and lateral region of the anterior midbrain. This effect is not relayed by endogenous FGF genes since exogenous FGFs inhibit the expression of endogenous XFGF3 or XFGF8. However, consequences of grafting MHB or implanting FGF4 or FGF8 beads on tadpole brain development are different. MHB grafts induce ectopic mesencephalic structures, strongly suggesting that a region homologous to the isthmic organizer of amniotes is specified as early as the midneurula stage. In contrast, exogenous FGFs do not cause the formation of ectopic mesencephalic structures but an overgrowth of mesencephalon and diencephalon. We propose that FGF signals from the prospective MHB play a crucial role in the spatial regulation of XWnt-1 and XEn-2 expression in the posterior midbrain, but that the full organizing activity of the MHB involves other factors in combination with FGF.
Riou
J F
JF
Laboratoire de Biologie Moléculaire et Cellulaire du Développement, groupe Biologie Expérimentale, UMR CNRS 7622, Université Paris VI, 9 quai Saint-Bernard, 75005, Paris, France.
Delarue
M
M
Méndez
A P
AP
Boucaut
J C
JC
D000818:Animals; D016380:Brain Tissue Transplantation; D004625:Embryo, Nonmammalian / Q000187:drug effects / Q000648:ultrastructure; D051519:Fibroblast Growth Factor 4; D051524:Fibroblast Growth Factor 8; D005346:Fibroblast Growth Factors / Q000096:biosynthesis / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D018507:Gene Expression Regulation, Developmental; D005801:Genes, Homeobox; D017403:In Situ Hybridization; D007814:Larva; D008636:Mesencephalon / Q000196:embryology* / Q000378:metabolism / Q000637:transplantation; D008863:Microspheres; D009024:Morphogenesis / Q000187:drug effects; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D012249:Rhombencephalon / Q000196:embryology / Q000378:metabolism / Q000637:transplantation; D016042:Transplantation, Heterotopic; D014982:Xenopus laevis / Q000196:embryology* / Q000235:genetics / Q000254:growth & development
D051519:Fibroblast Growth Factor 4; D011518:Proto-Oncogene Proteins; D051524:Fibroblast Growth Factor 8; D005346:Fibroblast Growth Factors